Brighter has been included in the Stockholm-Uppsala Life Science Investment Hotlist.
The Stockholm-Uppsala Investment Hotlist features a carefully selected list of investment cases from one of the world’s leading knowledge regions. Curated by Invest Stockholm, the list is a tool for investors focused on disruptive commercial innovation in life science.
”It is very gratifying and honoring to be welcomed to Invest Stockholm’s Investment Hotlist. Stockholm, with its access to high competence and world-class corporate and entrepreneurial culture, has provided a good basis for us in the product development phase and in the initial commercialization phase. We now aim to further strengthen our presence in the global market and look forward to curate the image of Sweden as a unicorn factory,” says Truls Sjöstedt, Brighter's CEO and founder.
To qualify for the list, the company must offer a product or service, based on unique research, with global commercial potential. It also must have established itself in the market with a finished product or service, or be close to the commercialization phase.
For further information, please contact:
Truls Sjöstedt, CEO
Phone: +46 709 73 46 00
Email: truls.sjostedt@brighter.se
Henrik Norström, COO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. https://brighter.se/
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.
About Actiste.
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent.
Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. https://actiste.com/